Skip to main content
. 2020 Sep 10;9(9):2921. doi: 10.3390/jcm9092921

Table 2.

Comparison of the results of questionnaires/scales between study groups.

Parameter IBD HC p
All Exacerbation Remission
PSQI 5 (4–7) 5 (4–8) 5 (3–6.8) 4 (2–6) 1 <0.001
3 <0.001
20.008
4 0.067
ESS 6 (4–9) 6 (4–10.5) 5 (3–7) 3 (2–7) 1 <0.001
3 <0.001
20.009
4 0.105
AIS 5.0 (4.0–8.0) 6.0 (4.0–9.0) 5.0 (3.0–7.0) 3.0 (1.0–6.0) 1 <0.001
3 <0.001
2 0.021
4 0.019
BDI 7.0 (4.0–11.0) 8.0 (5.0–12.0) 5.0 (2.0–9.8) 2.0 (1.0–4.0) 1 <0.001
3 <0.001
2 0.001
4 0.001
VAS 4.0 (0–5.0) 5.0 (2.0–5.5) 2.8 (0–4.9) 0 (0–3.0) 1 <0.001
3 <0.001
2 0.004
4 0.009
LPS 3.0 (0.0–5.0) 4.0 (2.0–6.0) 2.0 (0.0–3.0) 1.0 (0.0–3.0) 1 0.004
3 <0.001
20.001
4 0.617
Sleep latency [min] 15 (10–30) 15 (10–35) 15 (10–30) 10 (5–15) 1 <0.001
3 <0.001
2 0.352
4 0.009
Hours of sleep 7.0 (6.0–7.8) 7.0 (6.0–8.0) 7.0 (6.0–7.5) 6.8(6.0–7.3) 1 0.304
3 0.381
2 0.968
4 0.352
Hours spent in bed 8.0 (7.0–8.5) 8.0 (7.0–8.5) 8.0 (7.0–8.5) 7.0 (6.5–8.0) 1 <0.001
3 <0.001
2 0.824
4 0.002
Sleep efficiency (%) 88.9
(83.2–94.7)
88.9
(81.8–95.5)
89.4 (86.2–94.4) 97.2
(92.9–98.6)
1 <0.001
3 <0.001
2 0.662
4 <0.001
Waking up in the night n (%) 94 (70.7%) 66 (79.5%) 28 (56.0%) 24 (42.1%) 1 <0.001
3 <0.001
20.004
4 0.151

Data are presented as median (IQR) unless otherwise indicated. In bold—statistically significant differences regarding multiple testing correction between subgroups; 1 All vs HC; 2 Exacerbation vs Remission; 3 Exacerbation vs HC; 4 Remission vs HC; Abbreviations: AIS: Athens Insomnia Scale; BDI: Beck Depression Inventory; ESS: Epworth sleepiness scale; HC: health control; IBD: inflammatory bowel diseases; IQR: interquartile range; LPS: Laitinen Pain Scale; n: number; PSQI: Pittsburgh Sleep Quality Index; VAS: Visual Analogue Scale.